ONCOLOGY

Targeted and immunotherapy for GI and GU tumours.

An examination of survival rates for seven tumour types in seven different jurisdictions

American Society for Gastroenterology Endoscopy updates recommendations.

Current guidelines were based on expert opinion.

Data suggest that less is more in properly selected patients.

Toxicity profiles differ between the 2 approaches.

PLR can help identify high-risk patients for more aggressive treatment.

Action based on response rate and durability in patients with refractory disease.

Consider PTR in these patients, but factor age and primary tumor site, size, and differentiation into the decision.

Severe obstructive sleep apnoea may indicate the need for endoscopic screening for Barrett's oesophagus.

Study highlights “surprisingly low” risk of lymph node metastases and micrometastases with endoscopic treatment.

The study uses a larger and more detailed database than previous work.

About half of esophageal cancers recur within 2 years after surgery with curative intent.

First phase 2 randomized trial of add-on lapatinib with perioperative chemotherapy.